⚕ GalenOps CRO console
← 703 (USA)

703-1299

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 703 (USA) (Dr. Okafor) · consented 2012-09-12
Adverse events
8
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Moderate GLAUCOMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 1992; relationship: NONE

mild assessed 2026-08-18

Mild HYPOTENSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-01 (study day 171.0); relationship: REMOTE

moderate assessed 2026-08-18

Moderate HYPOTENSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-01 (study day 171.0); relationship: REMOTE

moderate assessed 2026-08-18

Moderate MYOCARDIAL INFARCTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-13 (study day 183.0); relationship: REMOTE

mild assessed 2026-08-18

Mild TACHYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-01 (study day 171.0); relationship: REMOTE

moderate assessed 2026-08-18

Moderate TACHYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-01 (study day 171.0); relationship: REMOTE

mild assessed 2026-08-18

Mild UPPER RESPIRATORY TRACT INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-27 (study day 16.0); relationship: NONE

mild assessed 2026-08-18

Mild UPPER RESPIRATORY TRACT INFECTION — outcome: RECOVERED/RESOLVED; onset 2012-09-27 (study day 16.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.